CA-BELKIN
7.6.2022 18:02:05 CEST | Business Wire | Press release
Belkin , a global consumer electronics leader, today announces three new additions to its growing SOUNDFORM audio portfolio – the SOUNDFORM Immerse Noise Cancelling Earbuds, the SOUNDFORM Play True Wireless Earbuds, and SOUNDFORM Nano Wireless Earbuds for Kids. The new SOUNDFORM solutions fill out Belkin’s vast true wireless audio collection, offering wireless earbuds for wide age ranges and at various price points.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607005084/en/
“Since launching the Belkin SOUNDFORM™ audio line just a few years ago, we introduced a variety of innovative audio solutions ranging from award-winning premium smart speakers to popular kids' headphones,” says Melody Tecson, senior director of product management, Belkin. “Our audio team has deep expertise in the acoustic industry and delivers high quality true wireless earbud solutions that will complement day-to-day activities from working out, taking work calls, or studying at home.”
SOUNDFORM™ Immerse Noise Cancelling Earbuds
Announced earlier this year at CES 2022, the SOUNDFORM Immerse Noise Cancelling Earbuds are Belkin’s top-of-the-line audio solution designed for true audiophiles who value a feature-rich solution and premium listening experience.
Key features:
- Hybrid ANC (Active Noise Cancellation) and 3 microphones per earbud filter and eliminate unwanted noise for clearer call quality and an ideal listening experience
- Hear-Thru mode enables users to adjust ambient sound levels so they can stay alert of their surroundings
- Multipoint connection offers seamless switching between multiple devices
- 12mm dual-layer dynamic drivers with neodymium magnets and aptX audio technology offer intensely vivid sounds and truly immersive audio moments
- 31 hours of battery life – 7 hours of playtime per charge for the earbuds, plus another 24 hours of battery in the wireless charging case for uninterrupted talking, listening, and streaming
- Locating capabilities with Apple Find My network to locate charging case, and Belkin Ping My Earbuds feature to locate earbuds
- Google Fast Pair allows Android phones to instantly connect with a simple tap
- Accompanying SOUNDFORM app provides advanced customization features such as personalized EQ settings and adjustable Hear-Thru levels
- Qi wireless charging case for quick and easy recharging
- IPX5-rated sweat and water resistance
- Black and White color options
SOUNDFORM™ Play True Wireless Earbuds
The SOUNDFORM Play True Wireless Earbuds are the next generation of Belkin’s original SOUNDFORM True Wireless Earbuds offering more features such as EQ presets, improved battery life, and four different color options at an affordable price.
Key features:
- Dual Beamforming technology with 2 microphones in each earbud reduces environmental noise and provides audio clarity on calls
- 38 hours of battery life — up to 8 hours of playtime for the earbuds, plus 30 hours in the charging case
- 3 touch-controllable EQ presets for personalized sound
- 6mm dynamic drivers deliver clear, dependable sound quality
- Fast USB-C charging fully charges case and buds in just 1.5 hours
- IPX5-rated sweat and water resistance
- Intuitive touch controls in both earbuds allows users to tap to skip tracks, answer calls and more
- Midnight, Cloud, Petal and Ocean color options
SOUNDFORM™ Nano Wireless Earbuds for Kids
The SOUNDFORM Nano Wireless Earbuds for Kids deliver safe, high-quality sound up to 85dB volume limit, all-day comfort and extended battery life so children ages 7+ can safely listen to audio. The SOUNDFORM Nano Wireless Earbuds join the SOUNDFORM Mini Wireless Headphones in Belkin’s audio collection specifically designed for kids.
Key features:
- Safe Sound for Kids 85dB volume limit protects young, sensitive hearing from loud sounds
- 5 different ear tip size options, including extra-extra small, assure a comfortable fit and premium listening experience for smaller ears
- 24 hours of battery life – up to 5 hours of non-stop playtime, with an additional 19 hours of battery life in the charging case
- 6mm dynamic driver in each earbud makes favorite songs come alive
- IPX5 water resistance keeps earbuds safe as kids splash through puddles, dash through light rain, and play carefree
- Case and earbuds are fully charged in just 2 hours with the included micro-USB cable
- Blue, Pink and White color options
Pricing and Availability
- The SOUNDFORM Immerse are now available to order for $179.99 USD on Belkin.com.
- The SOUNDFORM Play are now available to order for $59.99 USD on Belkin.com
- The SOUNDFORM Nano are now available to order for $49.99 USD on Belkin.com.
Imagery can be found HERE .
About Belkin
Belkin is an accessories market leader delivering power, protection, productivity, connectivity and audio solutions for a broad range of consumer electronics and enterprise environments. Designed in Southern California and sold in more than 50 countries around the world, Belkin creates products that empower people through technology whether at home, at work or on a new adventure. In 2018, Belkin International merged with Foxconn Interconnect Technology to bolster its global influence and remains forever inspired by people and the planet we live on.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220607005084/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom